Myoview™ (Technetium (99mTc) Tetrofosmin)
Adverse events reporting
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ .
Adverse events should also be reported to GE HealthCare at
gpv.drugsafety@gehealthcare.com
When efficiency matters
Myoview can provide earlier and faster imaging to help your department running efficiently and enhance the image quality. It may also help minimise the patient radiation exposure.
BENEFITS
Improve efficiency and image quality
Fast and efficient protocols
Myoview can provide earlier and faster imaging to help your department running efficiently
Simple preparation
High-quality images
Image quality offers diagnostic accuracy
Radiation exposure
The lower, approved dose range of Myoview may help minimize patient radiation exposure.
Support your need to efficiently visualize with efficiency and quality
Myoview can improve your image quality and workflow efficiency when localising myocardial ischaemia and infarction and assessing left ventricular function. Learn more about supporting resources available for Myoview.
Safety data for Myoview
Preparing Myoview
References
2. Duvall et al. J Nucl Cardiol 2020; 27: 254–265
3. Verberne HJ et al. Eur J Nucl Med Mol Imaging 2015; 42: 1929–1940
4. Jain D. Semin Nucl Med 1999; 29: 221–236
5. Kapur A et al. Eur J Nucl Med 2002; 29: 1608–1616
6. Underwood S et al. Eur J Nucl Med Mol Imaging 2004; 31: 261–291
7. Acampa W et al. J Nucl Cardiol 2000; 7: 701–707.
8. Münch G et al. J Nucl Med 1997; 38: 428–432
9. Technescan MIBI (Technetium [99mTc] sestamibi) Summary of Product Characteristics (UK), Curium Pharma, August 2021.